Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by TSG101 belongs to a group of apparently inactive homologs of ubiquitin-conjugating enzymes. Additionally we are shipping TSG101 Proteins (13) and TSG101 Kits (4) and many more products for this protein.
Showing 10 out of 114 products:
Hamster Monoclonal TSG101 Primary Antibody for ELISA, FACS - ABIN152256
Garrus, von Schwedler, Pornillos, Morham, Zavitz, Wang, Wettstein, Stray, Côté, Rich, Myszka, Sundquist: Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. in Cell 2001
Show all 65 references for ABIN152256
Human Polyclonal TSG101 Primary Antibody for EIA, IHC (p) - ABIN357572
Favre, Butticaz, Stevenson, Jongeneel, Telenti: High frequency of alternative splicing of human genes participating in the HIV-1 life cycle: a model using TSG101, betaTrCP, PPIA, INI1, NAF1, and PML. in Journal of acquired immune deficiency syndromes (1999) 2003
Show all 5 references for ABIN357572
Human Polyclonal TSG101 Primary Antibody for EIA, WB - ABIN357573
Lu, Hope, Brasch, Reinhard, Cohen: TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation. in Proceedings of the National Academy of Sciences of the United States of America 2003
Show all 5 references for ABIN357573
Dog (Canine) Monoclonal TSG101 Primary Antibody for WB - ABIN968912
Li, Cohen: Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. in Cell 1996
Show all 3 references for ABIN968912
Mouse (Murine) Polyclonal TSG101 Primary Antibody for IF, IHC - ABIN3023223
Yu, Yan, Yang, Wu, Ling, Chen, Tang, Tan, Cao, Wu, Yan, Wang: Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein. in Nature communications 2014
Cow (Bovine) Polyclonal TSG101 Primary Antibody for WB - ABIN2780311
Stefan, Claiborn, Stasiek, Chai, Ohta, Longnecker, Greally, Nicholls: Genetic mapping of putative Chrna7 and Luzp2 neuronal transcriptional enhancers due to impact of a transgene-insertion and 6.8 Mb deletion in a mouse model of Prader-Willi and Angelman syndromes. in BMC genomics 2005
Chicken Polyclonal TSG101 Primary Antibody for WB - ABIN2780762
Surjit, Oberoi, Kumar, Lal: Enhanced alpha1 microglobulin secretion from Hepatitis E virus ORF3-expressing human hepatoma cells is mediated by the tumor susceptibility gene 101. in The Journal of biological chemistry 2006
loss of ept alters nuclear cell cycle control in developing imaginal discs and the DaPKC, presenilin, and rbf1 genes as modifiers of molecular and cellular phenotypes that result from loss of ept
analysis of genetic interactions between the Drosophila tumor suppressor gene ept and the stat92E transcription factor
TSGDelta154-1054 splice variant increases TSG101 oncogenicity by inhibiting its E3-ligase-mediated proteasomal degradation.
Results show that TSG101 bidirectionally modulates cell invasion through regulating MMP-9 (show MMP9 Antibodies) mRNA expression in different cell types.
TSG101 plays an important role in the development of hepatocellular carcinoma
Expression of tsg101 mRNA and of TSG101 protein were significantly higher in the oxaliplatin resistant cell line than parent HT-29 cels.
PSAP (show PSAP Antibodies) motif of OFR3 is required for hepatitis E virus exit and interaction with host TSG101.
Stress-internalized EGFR (show EGFR Antibodies) is retained intracellularly by continued p38 (show CRK Antibodies) activity in a mechanism involving ubiquitin-independent, ESCRT/ALIX (show PDCD6IP Antibodies)-dependent incorporation onto intraluminal vesicles (ILVs (show IARS Antibodies)) of MVBs
Tsg101 is necessary for the efficient transport and release of nucleocapsids in marburg virus-infected cells
our findings strongly suggest that TSG101 is a cellular target for HSV-1 tegument ubiquitin specific protease activity during infection.
Our findings thus indicate that TSG101 regulation of p21 (show CDKN1A Antibodies) is an important factor in the cellular function of TSG101.
The ESCRT component TSG101 is required for optimal Human papillomavirus 16 infection.
BLOS1 (show BLOC1S1 Antibodies) interacts with sorting nexin 2 (show SNX2 Antibodies) and the ESCRT-I (show VPS28 Antibodies) component TSG101 to mediate the sorting of EGFR (show EGFR Antibodies) into endosomal compartments
pigment-type switching likely requires MGRN1's ubiquitin ligase activity but not its ability to bind TSG101 or NEDD4.
Tsg101 has a role in expression of EGFR (show EGFR Antibodies) and ErbB2 (show ERBB2 Antibodies) and preventing induction of autophagy prior to cell death
show that ubiquitin recognition by TSG101 is required for cSMAC formation, T cell receptor (TCR) microcluster signal termination, TCR downregulation.
Negative regulation of cell growth and differentiation by TSG101 through association with p21(Cip1/WAF1 (show CDKN1A Antibodies)).
Targeted deletion results in cell cycle arrest and p53 (show TP53 Antibodies)-independent cell death
our results suggest that Tsg101 is required for normal cell function of embryonic and adult tissues but that this gene is not a tumor suppressor for sporadic forms of breast cancer.
the TSG101 interaction with HRS is a crucial step in endocytic down-regulation of mitogenic signaling and this interaction may have a role in linking the functions of early and late endosomes
the Tsg101 protein has only weak oncogenic properties
results suggest that TSG101 is involved in the degradation of connexins via interaction with connexin proteins
The protein encoded by this gene belongs to a group of apparently inactive homologs of ubiquitin-conjugating enzymes. The gene product contains a coiled-coil domain that interacts with stathmin, a cytosolic phosphoprotein implicated in tumorigenesis. The protein may play a role in cell growth and differentiation and act as a negative growth regulator. In vitro steady-state expression of this tumor susceptibility gene appears to be important for maintenance of genomic stability and cell cycle regulation. Mutations and alternative splicing in this gene occur in high frequency in breast cancer and suggest that defects occur during breast cancer tumorigenesis and/or progression.
, tumor susceptibility Gene-101
, Tumor Susceptibility Gene homolog family member (tsg-101)
, ESCRT-I complex subunit TSG101
, tumor susceptibility gene 101 protein
, tumor susceptibility protein 101
, tumor susceptibility gene 101
, tumor susceptibility gene 10
, tumor susceptibility protein
, Tumor supressor